Results
). Since only the cDNA DVL3 were negative for all YACs, whereas PCR fragments of expected sizes were obtained in the reaction sequences of the human p63 gene were known, we set out to resolve the genomic structure via an exon bridging with total human DNA. LPP was positive only for YAC 949G9, indicating that this gene is just outside the LMS/ technique. Exon-specific primers were designed based on the proposed p63 gene structure (Yang et al., 1998 target sites. ⌬N-p63␣, the major p63 isotype in basal cells the formation of defective heterooligomers between TAp63␥ and ⌬N-p63␣
Cys306Arg
. The formation of defective hetof epithelial tissues (Yang et al., 1998), lacks transactivation capabilities against p53 reporter genes but rather erooligomeric complexes is also suggested by the effect of mutant ⌬N-p63␥ toward TA-p63␥ transactivation. shows remarkable dominant-negative activities toward transactivation of these genes by both p53 and TA-p63␥
Whereas wild-type ⌬N-p63␥ slightly stimulates rather than suppresses transactivation by TA-p63␥, repression (Yang et al., 1998). We asked whether the Cys306Arg substitution in ⌬N-p63␣ would affect these dominantof transactivation is brought about by ⌬N-p63␥
. It is likely that the ability of heterooligomer formation negative activities toward p53 and TA-p63␥ in the transfected cell model. As expected, wild-type ⌬N-p63␣ between mutant and wild-type p63 isotypes underlies the dominant nature of the p63 missense mutations in strongly repressed p53-induced transactivation of the p53 reporter gene (Figure 5B ), which is likely attributed EEC syndrome. We next investigated whether the frameshift mutation to effective competition for p53 DNA target sequences (Yang et al., 1998) . In contrast, coexpression of the had similar trans-dominant effects on transactivation. While TA-p63␣ normally lacks transactivation activity,
⌬N-p63␣
Cys306Arg mutant showed no significant effect on the transactivation activity of p53 ( Figure 5B ), which indiits truncated derivative, TA-p63␣FS, is a strong activator of reporter gene expression ( Figure 5D ). Thus, the TAcates that the mutation disrupts the DNA-binding ability of this p63 isotype. Similar effects toward p53 transactivap63␣FS mutant has not only maintained its DNA binding capacity but has also acquired transactivation activity tion were observed for wild-type and mutant ⌬N-p63␥ isotype ( Figure 5B ). The effects of ⌬N-p63␣ Cys306Arg excompared to TA-p63␣. TA-p63␣FS lacks almost half of the carboxy-terminal ␣ tail of TA-p63␣, which is compression on the transactivation functions of TA-p63␥ in this cell model were more complex than toward p53.
pletely absent in TA-p63␥. Apparently, the ␣ tail, or more specifically the domain that is encoded downstream of ⌬N-p63␣
Cys306Arg was as effective as wild-type ⌬N-p63␣ in blocking transactivation by TA-p63␥ ( Figure 5C ). There is evidence that the high incidence of mutations at these amino acids in p53 is yielded a significantly higher reporter gene expression than in the absence of ⌬N-p63␣FS ( Figure 5D ). Appardue to a combination of diverse environmental mutagens, that preferentially bind to CpG dinucleotides, and ently, ⌬N-p63␣FS is able to form potent transactivation complexes with the TA-p63 isoforms. A similar, but less strong positive selection for mutations, especially for those in the DNA-binding domain (Sidransky et al., 1992) . pronounced activity was observed for wild-type ⌬N-p63␥ in such cotransfection assays (Figures 5B and 5C) .
A similar mechanism of positive selection for mutations seems unlikely for p63. Examination of the nucleotide changes in the p63 gene reveals that six of nine mutations in EEC syndrome patients will partially or The localization of the genetic defect in EEC syndrome completely abolish DNA binding, either because the family Ams-1 to the 3q27 region was unexpected, be-DNA contacting amino acids are mutated or because of cause in a previous study significant support was obdisruption of the structural integrity of the DNA-binding tained for a location on chromosome 19 (Table 1; surface. As a consequence of the diminished DNA bind-O'Quinn et al., 1998). It is possible that the linkage deing, the transactivation capacity of the mutant protein tected at one of these loci is spurious. Alternatively, the will also be reduced. Indeed, cell lysates containing the identification of linkage to two loci may be indicative TA-p63␥ isotype with the Cys306Arg mutation showed for the involvement of genes from the corresponding a total lack of transactivation activity, whereas lysates chromosomal regions acting in concert in developwith the normal TA-p63␥ isotype do activate transcripmental processes that are disturbed in this family. cannot be concluded yet which mechanism, haploinsuftoward TA-p63␥, with which complex formation is possible, while it has retained its suppressive effect on p53-ficiency, dominant-negative, or gain of function, is applicable. Also, the full constellation of symptoms observed mediated transactivation. in EEC syndrome might be caused by a combination of these mechanisms, as was previously found for several Causal Heterogeneity of Mechanisms Leading p53 mutations in human tumors (for reviews see Zamto EEC Syndrome betti and Levine, 1993; Ko and Prives, 1996; Levine, An inherent consequence of the gene structure of p63 1997). The existence of different p63 isotypes with differis that the mutations observed will affect the function ent properties may complicate the effect of mutations of multiple p63 isotypes. The missense mutations are even more. predicted to affect all six known p63 isotypes, resulting We feel, however, that haploinsufficiency is not a likely both in a loss of transactivation by TA-p63␥ and to a explanation, because patients with germline deletions disruption of repressive properties of other isotypes toof chromosome 3q27-qter lack the defining features of ward TA-p63␥. The frameshift mutation, which was EEC/LMS (Chitayat et al., 1996 and references therein).
found in a patient with a typical EEC syndrome, should In addition, the p63 homozygous knockout mice that not interfere with the production of either the p63␥ or were recently created have severe ectodermal defects p63␤ variants. Consequently, EEC syndrome is not due and limb anomalies which recall most of the characteristo a loss of p63 transactivation per se, since the transtics of EEC/LMS, but heterozygous wt/Ϫ mice have no activating isotype (TA-p63␥) is left intact. Instead, the obvious phenotypic abnormalities (Mills et al., 1999; frameshift mutation results in a gain of transactivation Yang et al., 1999). It thus seems that the human p63 activity for the truncated TA-p63␣ isotype. The missense mutant proteins found in EEC syndrome exert a domiand frameshift mutations appear to exhibit divergent nant-negative or a gain-of-function effect. The acquired effects on the regulation of transcriptional activity of transactivation activity of TA-p63␣ with the carboxyp63 as well. The Cys306Arg missense mutation supterminal truncation could be a gain of function (Figure presses the p63-mediated transactivation, whereas the 5D). However, due to the ability of p63 isotypes to form frameshift mutation has a stimulatory effect. The above homo-and heterooligomeric complexes, this mutation, data suggest that both an increase and a decrease of like the Cys306Arg mutation, also has dominant-negatransactivation by p63 lead to the developmental detive properties in other transactivation assays. Heterofects seen in EEC syndrome patients. Of course, this oligomeric complex formation underlies the normal supobservation is based on transactivation studies with a pressive and slightly stimulatory activities of the ⌬N-p63␣ target gene under control of a p53 response element. and ⌬N-p63␥ isotypes, respectively, toward TA-p63␥
The effects in vivo on the transcriptional regulation of transactivation ( Figure 5C; Yang et al., 1998) . Incorporathe normal p63 target genes may be dependent on addition of mutant isotypes may alter the properties of the tional factors such as the DNA-binding sequence and entire complex. Indeed, the existence of such comthe nuclear environment. promised complexes is suggested by our finding that mutant ⌬N-p63␥ Cys306Arg has repressive effects toward TA-p63␥ transactivation. ⌬N-p63␥ Cys306Arg has no effect The EEC Phenotype Resembles that of p63 Knockout Mice toward transactivation by p53, with which it is unable to complex (Figure 5) . Likewise, the normal repressive A comparison of the phenotype of p63 Ϫ/Ϫ mice with that of patients who have EEC syndrome shows a strikingly activity of ⌬N-p63␣ is converted into a stimulatory effect 
